PHAXIAM Therapeutics S.A. Current Derivative Financial Liabilities
PHAXIAM Therapeutics S.A. had Current Derivative Financial Liabilities of EUR 0 as of 2023-06-30, per its 6-K filed 2023-09-26.
Discontinued › Notes › Derivative Instruments and Hedging Activities
ifrs-full:CurrentDerivativeFinancialLiabilities · last filed 2023-09-26
- 2023-06-30: Current Derivative Financial Liabilities 0.00 EUR.
- 2022-12-31: Current Derivative Financial Liabilities 0.00 EUR.
- 2022-06-30: Current Derivative Financial Liabilities 0.00 EUR.
- 2021-12-31: Current Derivative Financial Liabilities 0.00 EUR.
| Period end | Current Derivative Financial Liabilities |
|---|---|
| 2023-06-30 | 0.00 EUR 6-K · filed 2023-09-26 |
| 2022-12-31 | 0.00 EUR 6-K · filed 2023-09-26 |
| 2022-06-30 | 0.00 EUR 6-K · filed 2022-09-12 |
| 2021-12-31 | 0.00 EUR 20-F · filed 2023-03-28 |
| 2021-06-30 | 3.00K EUR 6-K · filed 2021-09-20 |
| 2020-12-31 | 129.00K EUR 20-F · filed 2023-03-28 |
| 2019-12-31 | 0.00 EUR 20-F · filed 2022-04-27 |
| 2018-12-31 | 0.00 EUR 20-F · filed 2021-03-08 |